Cancer Genetics Inc. (CGIX) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Thu November 12th, 2020

- 22:31
  Press ReleasesSHAREHOLDER ALERT: WeissLaw LLP Investigates Cancer Genetics, Inc.PR Newswire

Fri October 9th, 2020

- 12:01
  Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings LimitedPR Newswire

Mon October 5th, 2020

- 11:30
  Press ReleasesInvitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients WorldwidePR Newswire

Mon September 28th, 2020

- 13:28
  Press ReleasesLarge Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer GeneticsPR Newswire

Fri September 25th, 2020

- 20:55
  Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)PR Newswire

Fri September 11th, 2020

- 00:50
  Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings LimitedPR Newswire

Mon August 31st, 2020

- 15:36
  Press ReleasesINVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Cancer Genetics, Inc. - CGIXPR Newswire

Sat August 29th, 2020

- 18:01
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDigestWall Street Breakfast: What Moved MarketsSeeking Alpha

Wed August 26th, 2020

- 22:39
  Press ReleasesLifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings LimitedPR Newswire

Tue August 25th, 2020

- 10:20
  Press ReleasesCancer Genetics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Cancer Genetics, Inc. is Fair to Shareholders; Investors are Encouraged to Contact the FirmPR Newswire

Mon August 24th, 2020

- 15:45
  Press ReleasesAnalysisThinking about buying stock in ADMA Biologics, Aldeyra Therapeutics Inc, Cancer Genetics Inc, Borqs Technologies, or Liminal BioSciences?PR Newswire

Mon June 22nd, 2020

- 11:00
  Press ReleasesInvitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncologyPR Newswire

Tue June 16th, 2020

- 17:15
  Press ReleasesInsights on the Cervical Cancer Diagnostic Testing Market to 2027 - Featuring BioVantra, Cancer Genetics & Cepheid Among OthersPR Newswire

SPY$393.840.53%

QQQ$337.24%

DOW$59.01-7.3%

GME$53.33-42%

NVCR$192.1711%

PLUG$64.6929%

PSTG$29.3314%

VIV$9.0410%

SPY$393.840.53%

QQQ$337.24%

DOW$59.01-7.3%

GME$53.33-42%

NVCR$192.1711%

PLUG$64.6929%

PSTG$29.3314%

VIV$9.0410%

About Developer Contact